Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aulis Capital
Palo Alto, California, USA
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Aulis Capital is a global venture capital firm dedicated to the healthcare, life sciences, and biotechnology sectors. Founded in 2025 by industry veteran Nisa Leung, formerly of Qiming Venture Partners, the firm operates out of strategic hubs in Palo Alto, Boston, Shanghai, Beijing, and Hong Kong. Aulis Capital specializes in early to growth-stage investments, leveraging deep scientific and clinical expertise to scale transformative innovations in drug discovery, medical technology, and digital health. The firm's portfolio includes pioneering companies such as EpiBiologics, which develops tissue-selective protein degraders, and several leaders in tech-enabled healthcare platforms and diagnostics. By bridging innovation between the United States and Asian markets, Aulis Capital aims to accelerate the development of solutions that improve global patient outcomes.
- Therapeutic areas
- OncologyNeurologyRare DiseasesInfectious Diseases
- Modalities
- Small moleculeMonoclonal antibodyBispecific monoclonal antibodyDigital HealthDiagnostics
- Industry
- Investors
Beyond the preview
Go deeper on Aulis Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aulis Capital.